Position in MRVI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,570,276
+$2,575,368 QoQ
Shares Held
572,160
+62.7% QoQ
Ownership
0.220%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 177 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. MRVI ranks #95 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in MRVI
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,570,276 | 572,160 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $994,908 | 351,558 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,123,761 | 345,773 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $883,426 | 307,815 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $680,081 | 282,192 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $534,149 | 241,697 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,231,403 | 225,946 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,877,467 | 225,929 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,633,817 | 228,187 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,548,503 | 639,966 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,397,257 | 213,322 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,577,470 | 157,747 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,764,851 | 383,335 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,954,788 | 353,661 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $5,605,309 | 391,706 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $38,643,252 | 1,513,641 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $41,893,951 | 1,474,620 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $43,303,905 | 1,227,783 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $56,172,563 | 1,340,634 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $154,302,806 | 3,143,904 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $174,695,466 | 4,186,328 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $143,548,581 | 4,027,738 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $110,837,778 | 3,951,436 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||